Risk of second primary cancer in patients with head and neck squamous cell carcinoma: a systemic review and meta-analysis
- PMID: 37540282
- DOI: 10.1007/s00784-023-05066-3
Risk of second primary cancer in patients with head and neck squamous cell carcinoma: a systemic review and meta-analysis
Abstract
Objectives: Second primary cancer is a common event in patients with head and neck squamous cell carcinoma. However, the incidence and relevant factors vary by studies. We conducted a systematic review and meta-analysis of observational studies to estimate the incidence and relevant risk factors.
Materials and methods: PubMed and Web of Science were searched for studies published between January 2000 and December 2020 that reported the incidence of SPC in HNSCC patients. Per 1000-person-year incidence and odds ratios were used to estimate the incidence and potential risk factors. Due to the high heterogeneity, random-effects models were used to estimate the incidence and 95% confidence interval.
Results: Seven thousand seven hundred thirteen articles were identified from the databases, in which 60 studies were included in this meta-analysis. The pooled incidence of the total, synchronous, and metachronous SPC in patients with HNSCC were 29.116 per 1000-person-year, 6.960 per 1000-person-year, and 26.025 per 1000-person-year, respectively. The head and neck region was the most common area where SPC occurred, followed by the lung (7.472 per 1000-person-year) and upper digestive tract (2.696 per 1000-person-year). Smoking, alcohol consumption, betel quid chewing, primary cancer of T1-2, and N0 were risk factors, while HPV infection (OR 0.47, 95% CI 0.30-0.72) was the protective factor.
Conclusions: SPC is frequently observed in HNSCC patients and had great impact on the prognosis. The findings could promote a more individualized follow-up strategy for SPC in HNSCC patients.
Clinical relevance: This systemic review and meta-analysis provide sufficient evidence for the establishment of the follow-up strategy for head and neck squamous cancer patients.
Keywords: Head and neck squamous cell carcinoma; Meta-analysis; Person-year incidence; Risk factors; Second primary cancer.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.Cochrane Database Syst Rev. 2016 Dec 11;12(12):CD010963. doi: 10.1002/14651858.CD010963.pub2. Cochrane Database Syst Rev. 2016. PMID: 27943254 Free PMC article.
-
Sun protection for preventing basal cell and squamous cell skin cancers.Cochrane Database Syst Rev. 2016 Jul 25;7(7):CD011161. doi: 10.1002/14651858.CD011161.pub2. Cochrane Database Syst Rev. 2016. PMID: 27455163 Free PMC article.
-
The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta-analysis.Cancer Rep (Hoboken). 2023 Mar;6(3):e1776. doi: 10.1002/cnr2.1776. Epub 2022 Dec 27. Cancer Rep (Hoboken). 2023. PMID: 36573562 Free PMC article.
Cited by
-
Age-stratified associations between radiotherapy and SPMs for FPHNC: a population-based cohort study.Mil Med Res. 2025 May 21;12(1):22. doi: 10.1186/s40779-025-00612-4. Mil Med Res. 2025. PMID: 40399955 Free PMC article.
-
Head and neck squamous cell carcinoma in adults aged 45 or younger-an analysis of two tertiary cancer centres.Strahlenther Onkol. 2025 Aug 21. doi: 10.1007/s00066-025-02448-2. Online ahead of print. Strahlenther Onkol. 2025. PMID: 40839041
-
Survival and risk factors for metastatic colorectal cancer patients with a history of prior malignancy.Sci Rep. 2025 Feb 3;15(1):4045. doi: 10.1038/s41598-025-88555-7. Sci Rep. 2025. PMID: 39900612 Free PMC article.
-
Oral and periodontal manifestation related during human papilloma virus infections: Update on early prognostic factors.Heliyon. 2024 May 14;10(10):e31061. doi: 10.1016/j.heliyon.2024.e31061. eCollection 2024 May 30. Heliyon. 2024. PMID: 38813162 Free PMC article. Review.
References
-
- Sung H, Hyun N, Leach CR et al (2020) Association of first primary cancer with risk of subsequent primary cancer among survivors of adult-onset cancers in the United States. JAMA 324(24):2521–2535. https://doi.org/10.1001/jama.2020.23130 - DOI - PubMed - PMC
-
- Baxi SS, Pinheiro LC, Patil SM et al (2014) Causes of death in long-term survivors of head and neck cancer. Cancer 120(10):1507–1513. https://doi.org/10.1002/cncr.28588 - DOI - PubMed
-
- Simpson MC, Massa ST, Boakye EA et al (2018) Primary cancer vs competing causes of death in survivors of head and neck cancer. JAMA Oncol 4(2):257–259. https://doi.org/10.1001/jamaoncol.2017.4478 - DOI - PubMed
-
- van der Schroeff MP, van de Schans SA, Piccirillo JF et al (2010) Conditional relative survival in head and neck squamous cell carcinoma: permanent excess mortality risk for long-term survivors. Head Neck 32(12):1613–1618. https://doi.org/10.1002/hed.21369 - DOI - PubMed
-
- Collins C, Frese T, Merode TV et al (2020) General practice and the community: research on health service, quality improvements and training. Selected abstracts from the EGPRN Meeting in Vigo, Spain, 17–20 October 2019. Eur J Gen Pract 26(1):42–50. https://doi.org/10.1080/13814788.2020.1719994 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical